Pharmalucence formally CIS-US Inc.
Careers News Resources Contact  
  Manufacturing Capabilities
  Facility Details 
  Nuclear Medicine Products

Kit for the Preparation of Technetium Tc99m Sestamibi Injection
Kit for the Preparation of Technetium Tc99m Mebrofenin
Kit for the Preparation of Technetium Tc99m Pyrophosphate Injection
HepatoliteŽ Kit for the Preparation of Technetium Tc99m Disofenin for Injection
Kit for the Preparation of Technetium Tc99m Medronate for Injection
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection
Radiopharmaceutical Vial Shields
Pharmalucence Generic Sestamibi
Kit for the Preparation of Technetium
Tc99m Sestamibi Injection


Download Product
Package Insert
Download MSDS

Cost Effectiveness
Competitively priced 5 vial kits (SES05) and 30 vial packs (SES30).

To order, call now: 1-800-221-7554

Significant quantity based purchase discounts are available, please contact Customer Service for details.

  No reporting requirements, no fee per dose pricing, no licensing.

Direct vial sale with no strings attached.

  The FDA has determined that Pharmalucence Sestamibi is bioequivalent and therapeutically equivalent to the Referenced Listed Drug (RLD)*.

Indications and usage: Technetium Tc 99m Sestamibi, is a myocardial perfusion agent indicated for:

 Detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects).

 Evaluating myocardial function and developing information for use in patient management decisions.

Important safety information:

 Pharmacologic induction of cardiovascular stress may be associated with serious adverse events such as myocardial infarction, arrhythmia, hypotension, bronchoconstriction and cerebrovascular events.

 Technetium Tc 99m Sestamibi has been rarely associated with acute severe allergic and anaphylactic events of angioedema and generalized urticaria. In some patients the allergic symptoms developed on the second injection during Technetium Tc 99m Sestamibi imaging.

 Caution should be exercised and emergency equipment should be available when administering Technetium Tc 99m Sestamibi.

 Before administering Technetium Tc 99m Sestamibi patient should be asked about the possibility of allergic reactions to either drug.

 The contents of the vial are intended only for use in the preparation of Technetium Tc 99m Sestamibi and are not to be administrated directly to the patient without first undergoing the preparative procedure.

* The Referenced Listed Drug (RLD) for the generic Pharmalucence Technetium Tc99m Sestamibi Kit is CardioliteŽ, a registered trademark of Lantheus Medical Imaging, Inc.
  During these times of diminished reimbursement, greater emphasis on cost control and increasing technetium prices, Pharmalucence generic sestamibi provides you the means to realize significant radiopharmaceutical cost savings.


To Place Your Order
  Contact Customer Service at

29 Dunham Road, Billerica, MA 01821 | Telephone: 781-275-7120    © Pharmalucence Inc. All rights reserved.